Medicine

Special Project

At the genetic level: how pharma company Darnitsa, founded 90 years ago, manages to combine traditionіs and innovations

And ways to encourage employees to build a progressive future
Special Project

Billions against epidemic: how pharmaceutical world is weathering the crisis

And why pharmacists spare no money on innovation

Healthy growth: why pharma’s future lies with generics

Ukrainian pharmaceutical market will grow and stay popular among the investors in the next years. The generic drugs producers will win the most

«Darnitsa» increases its net profit by 31%

No dividends will be paid. The net profit of UAH 449 134 thousands will be reinvested for the companys financial needs

Life Elixir: how a pharmaceutical company launched the production of infusions

And why is it unique for Ukraine.

Medical investment: where Ukrainian pharmacy needs support

What factors can attract foreign capital into the industry